News tagged with oseltamivir
Improved molecular tools streamline influenza testing and management
Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore ...
Diseases, Conditions, Syndromes
Apr 17, 2013 |
not rated yet |
0
Beware fake flu treatments, FDA warns
(HealthDay)—With the height of flu season here, the U.S Food and Drug Administration warns consumers to avoid fraudulent products that claim to prevent, treat or cure the flu.
Medications
Feb 04, 2013 |
not rated yet |
0
FDA expands tamiflu use to treat babies under one year old
(HealthDay)—Tamiflu (oseltamivir) can now be given to children as young as 2 weeks old under an expanded approval announced Friday by the U.S. Food and Drug Administration.
Medications
Dec 22, 2012 |
not rated yet |
2
Early use of antiviral medications may help prevent lung failure in children with the flu, reduce hospitalizations
(Medical Xpress)—Children hospitalized for the flu are much less likely to require breathing support from a mechanical ventilator if they receive antiviral drugs like oseltamivir (Tamiflu) as soon as possible after admission, ...
Diseases, Conditions, Syndromes
Nov 08, 2012 |
not rated yet |
0
BMJ editor urges Roche to fulfil promise to release Tamiflu trial data
In an open letter to company director, Professor Sir John Bell, she says: "Billions of pounds of public money have been spent on [Tamiflu] and yet the evidence on its effectiveness and safety remains hidden from appropriate ...
Medications
Oct 30, 2012 |
not rated yet |
0
Tamiflu doesn't offer relief promised, study finds
For the nearly 62 million Americans infected with influenza each year, oeseltamivir, commonly called Tamiflu, promises to offer relief. New research from the University of Georgia finds the medication may not have all of ...
Medications
Oct 26, 2012 |
4 / 5 (2) |
1
|
A new approach to deadly influenza outbreaks in nursing homes
(Medical Xpress)—In developed countries people over 65 years old are the most likely to die from an influenza outbreak and people in nursing homes, where the virus is difficult to control, are especially vulnerable.
Diseases, Conditions, Syndromes
Oct 18, 2012 |
not rated yet |
0
|
Scientists explain how they created bird flu that spreads easily among mammals
Scientists have created versions of the H5N1 bird flu that spread easily among mammals through droplets in sneezes and have concluded that the deadly virus could trigger a global pandemic in humans.
Diseases, Conditions, Syndromes
Jun 22, 2012 |
4.2 / 5 (6) |
0
|
Tamiflu: Full reports from trials should be public; regulators respond to recommendations
The full clinical study reports of drugs that have been authorized for use in patients should be made publicly available in order to allow independent re-analysis of the benefits and risks of such drugs, according to leading ...
Medications
Apr 10, 2012 |
not rated yet |
0
Continuing uncertainties surround anti-influenza drug
Incomplete availability of data has hampered a thorough assessment of the evidence for using the anti-influenza drug oseltamivir, a Cochrane Review has found. However, after piecing together information from over 16,000 pages ...
Medications
Jan 18, 2012 |
not rated yet |
0
Swine flu strain that is resistant to Tamiflu is spreading more easily
The flu season is still young in the United States and the rest of the Northern Hemisphere, but Australia wrapped up its flu season months ago, and public health officials there have some disturbing news to report: The version ...
Diseases, Conditions, Syndromes
Dec 29, 2011 |
5 / 5 (2) |
0
Searchers map the global spread of drug-resistant influenza
In the new movie "Contagion," fictional health experts scramble to get ahead of a flu-like pandemic as a drug-resistant virus quickly spreads, killing millions of people within days after they contract the illness.
Diseases, Conditions, Syndromes
Sep 14, 2011 |
not rated yet |
0
|
Popular flu medication's neurologic side effects in children studied
Oseltamivir is the weapon of choice for preventing influenza infection from taking hold, but like any other drug, it also has the potential for adverse effects. Children in particular are susceptible ...
Medical research
Sep 09, 2011 |
5 / 5 (1) |
0
Oseltamivir
Oseltamivir INN ( /ɒsəlˈtæmɨvɪər/), an antiviral drug, slows the spread of influenza (flu) virus between cells in the body by stopping the virus from chemically cutting ties with its host cell; median time to symptom alleviation is reduced by 0.5–1 day. The drug is sold under the trade name Tamiflu, and is taken orally in capsules or as a suspension. It has been used to treat and prevent influenza A virus and influenza B virus infection in over 50 million people since 1999.[citation needed]
Oseltamivir is a prodrug, a (relatively) inactive chemical which is converted into its active form by metabolic process after it is taken into the body. It was the first orally active neuraminidase inhibitor commercially developed.[citation needed] It was developed by C.U. Kim, W. Lew, and X. Chen of US-based Gilead Sciences, and is currently marketed by Hoffmann–La Roche (Roche). In Japan, it is marketed by Chugai Pharmaceutical Co., which is more than 50% owned by Roche.
As of December 2010[update], the World Health Organization (WHO) reported 314 samples of the prevalent 2009 pandemic H1N1 flu tested worldwide have shown resistance to oseltamivir.
For more information about Oseltamivir, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
